121 related articles for article (PubMed ID: 14599065)
1. Improved final height in Turner's syndrome following growth-promoting treatment at a single centre.
Gault EJ; Paterson WF; Young D; Donaldson MD
Acta Paediatr; 2003 Sep; 92(9):1033-8. PubMed ID: 14599065
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
Morin A; Guimarey L; Santucci Z; Apezteguia M
Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
[TBL] [Abstract][Full Text] [Related]
3. Final height in Turner syndrome patients treated with growth hormone.
Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
[TBL] [Abstract][Full Text] [Related]
4. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
5. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
Morin A; Guimarey L; Apezteguia M; Santucci Z
Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
[TBL] [Abstract][Full Text] [Related]
6. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
7. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
[TBL] [Abstract][Full Text] [Related]
8. Optimization of treatment in Turner's syndrome.
Gracia Bouthelier R; Oliver Iguacel A; Gonzalez Casado I; Alcalde de Alvaré A
J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():427-34. PubMed ID: 15134303
[TBL] [Abstract][Full Text] [Related]
9. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
[TBL] [Abstract][Full Text] [Related]
10. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
[TBL] [Abstract][Full Text] [Related]
12. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
Mul D; Oostdijk W; Waelkens JJ; Drop SL
Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
[TBL] [Abstract][Full Text] [Related]
13. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
[TBL] [Abstract][Full Text] [Related]
14. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
[TBL] [Abstract][Full Text] [Related]
15. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome in Turner syndrome.
Parvin M; Roche E; Costigan C; Hoey HM
Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
[TBL] [Abstract][Full Text] [Related]
17. [Optimizing estrogen treatment in Turner syndrome].
Ságodi L; Sólyom E
Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
[TBL] [Abstract][Full Text] [Related]
18. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
Ranke MB; Schweizer R; Martin DD; Ehehalt S; Schwarze CP; Serra F; Binder G
Horm Res Paediatr; 2012; 77(4):214-21. PubMed ID: 22433161
[TBL] [Abstract][Full Text] [Related]
19. Turner's syndrome.
Guarneri MP; Abusrewil SA; Bernasconi S; Bona G; Cavallo L; Cicognani A; Di Battista E; Salvatoni A;
J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():959-65. PubMed ID: 11529402
[TBL] [Abstract][Full Text] [Related]
20. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome.
Carel JC; Mathivon L; Gendrel C; Ducret JP; Chaussain JL
J Clin Endocrinol Metab; 1998 May; 83(5):1462-6. PubMed ID: 9589639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
